Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33035459

Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Nov
First author
Gounder M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Nov;21(11):1388-1390. doi: 10.1016/S1470-2045(20)30530-1.
    note
    Source null
    related pmid
    33035458
    relationship
    Comment in

Authors and identifiers

  1. name
    Gounder M
    type
    Author
  2. name
    Schöffski P
    type
    Author
  3. name
    Jones RL
    type
    Author
  4. name
    Agulnik M
    type
    Author
  5. name
    Cote GM
    type
    Author
  6. name
    Villalobos VM
    type
    Author
  7. name
    Attia S
    type
    Author
  8. name
    Chugh R
    type
    Author
  9. name
    Chen TW
    type
    Author
  10. name
    Jahan T
    type
    Author
  11. name
    Loggers ET
    type
    Author
  12. name
    Gupta A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gounder M
    type
    Author
  2. name
    Schöffski P
    type
    Author
  3. name
    Jones RL
    type
    Author
  4. name
    Agulnik M
    type
    Author
  5. name
    Cote GM
    type
    Author
  6. name
    Villalobos VM
    type
    Author
  7. name
    Attia S
    type
    Author
  8. name
    Chugh R
    type
    Author
  9. name
    Chen TW
    type
    Author
  10. name
    Jahan T
    type
    Author
  11. name
    Loggers ET
    type
    Author
  12. name
    Gupta A
    type
    Author
bibliography ids
  1. nci-bib-af01f4de1c494b10a57bc908
book metadata
content sha256
7a8b6fafd4c067eb2b9e5f27ddc568eb81104412a8df8596d4c682368f4eb909
document type
citation
dois
  1. 10.1016/S1470-2045(20)30451-4
electronic publication date
display
2020 Oct 6
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:33035459
immutable id
pubmed:33035459@7a8b6fafd4c067eb2b9e5f27ddc568eb81104412a8df8596d4c682368f4eb909
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1423-1432
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Nov;21(11):1388-1390. doi: 10.1016/S1470-2045(20)30530-1.
    note
    Source null
    related pmid
    33035458
    relationship
    Comment in
outcomes validated
false
pmid
33035459
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
aab681e11ee065d84cc9d26685930d06844f9ba3ee0e68cea2db0e454fdf3ca7
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2020 Nov
precision
month
year
2020
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33035459/
title
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.

Preserved source evidence · Not medical advice